1 |
MASP2
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Narsoplimab
Narsoplimab
💬
|
Narsoplimab
| 4件: 64 64, 66, 109, 222 💬 |
2 |
CFD
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Danicopan
Danicopan
💬
|
Danicopan
| 1件: 62 62 💬 |
3 |
IL10
💬
| 22件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, FoxO signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Pertussis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Staphylococcus aureus infection, Tuberculosis, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Systemic lupus erythematosus, Allograft rejection | Pirfenidone
Pirfenidone
💬
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
4 |
ITGAL
💬
| 12件: Rap1 signaling pathway Rap1 signaling pathway, Cell adhesion molecules, Neutrophil extracellular trap formation, Natural killer cell mediated cytotoxicity, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Malaria, Staphylococcus aureus infection, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis | Efalizumab
Efalizumab
💬
|
Efalizumab
| 9件: 11 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
5 |
PLG
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A | Aminocaproic acid
Aminocaproic acid
💬
|
Aminocaproic acid
| 1件: 70 70 💬 |
6 |
PLG
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A | Tranexamic acid
Tranexamic acid
💬
|
Tranexamic acid
| 7件: 46 46, 70, 215, 227, 274, 288, 299 💬 |
7 |
PTAFR
💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection | Rupatadine
Rupatadine
💬
|
Rupatadine
| 1件: 46 46 💬 |
8 |
CFB
💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Iptacopan
Iptacopan
💬
|
Iptacopan
| 5件: 61 61, 62, 66, 109, 222 💬 |
9 |
C1R
💬
| 6件: Phagosome Phagosome, Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 1件: 61 61 💬 |
10 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Conestat alfa
Conestat alfa
💬
|
Conestat alfa
| 1件: 61 61 💬 |
11 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Sutimlimab
Sutimlimab
💬
|
Sutimlimab
| 1件: 61 61 💬 |
12 |
C3
💬
| 17件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phagosome, Complement and coagulation cascades, Neutrophil extracellular trap formation, Alcoholic liver disease, Shigellosis, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, Staphylococcus aureus infection, Tuberculosis, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Viral carcinogenesis, Systemic lupus erythematosus | Pegcetacoplan
Pegcetacoplan
💬
|
Pegcetacoplan
| 4件: 2 2, 61, 62, 222 💬 |
13 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Eculizumab
Eculizumab
💬
|
Eculizumab
| 7件: 11 11, 13, 14, 61, 62, 109, 222 💬 |
14 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Ravulizumab
Ravulizumab
💬
|
Ravulizumab
| 7件: 2 2, 11, 13, 50, 62, 66, 109 💬 |
15 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Nomacopan
Nomacopan
💬
|
Nomacopan
| 3件: 62 62, 109, 162 💬 |
16 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Pozelimab
Pozelimab
💬
|
Pozelimab
| 2件: 11 11, 62 💬 |
17 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Crovalimab
Crovalimab
💬
|
Crovalimab
| 2件: 62 62, 109 💬 |
18 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Vilobelimab
Vilobelimab
💬
|
Vilobelimab
| 3件: 43 43, 44, 269 💬 |
19 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Zilucoplan
Zilucoplan
💬
|
Zilucoplan
| 3件: 2 2, 11, 62 💬 |
20 |
C5AR1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Alcoholic liver disease, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Avacopan
Avacopan
💬
|
Avacopan
| 3件: 43 43, 44, 222 💬 |